Used in research for its potential as a selective inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2, CDK4, and CDK9. These enzymes play key roles in cell cycle regulation and transcription, making the compound relevant in oncology studies. It has shown antiproliferative effects in various cancer cell lines, helping scientists explore new pathways for tumor growth inhibition. Due to its ability to interfere with cell cycle progression, it is utilized as a tool compound in preclinical studies to understand CDK-driven cancers and assess therapeutic strategies. Not intended for clinical use; strictly for laboratory research.